BioSpace News Archive

FDA

Vanda Applauds White House Issuance of Executive Orders Requiring Federal Agencies to be Transparent in Policymaking and Enforcement

The recent Executive Orders appropriately identify the issues associated with the issuance of guidance documents.

October 16, 2019
·
2 min read
Business

Globus Medical Schedules Third Quarter 2019 Earnings Release and Conference Call

A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.

October 16, 2019
·
1 min read
Drug Development

Regulus Therapeutics Presents Preclinical Data Identifying RGLS4326 as a Potential Disease-Modifying Treatment for Autosomal Dominant Polycystic Kidney Disease at OTS Annual Meeting

The poster presentation is available for download at http://regulusrx.com/publications.

October 16, 2019
·
3 min read
Business

CryoLife Announces Release Date and Teleconference Call Details for 2019 Third Quarter Financial Results

On that day, the Company will hold a teleconference call and live webcast at 5:30 p.m. ET to discuss the results

October 16, 2019
·
1 min read
Biotech Bay

Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

Sutro discovered and manufactures STRO-002 using its proprietary XpressCF+™ cell-free protein synthesis technology.

October 16, 2019
·
5 min read
Bio NC

cbdMD, Inc. Announces Closing of $5.0 Million 8.0% Series A Cumulative Convertible Preferred Stock Offering

The shares are expected to begin trading on the NYSE American LLC under the symbol “YCBD PR A” on October 21, 2019.

October 16, 2019
·
3 min read
Business

Sempre Health Honored By Goldman Sachs For Entrepreneurship

Founder and CEO Anurati Mathur Among 100 Most Intriguing Entrepreneurs at 2019 Builders + Innovators Summit

October 16, 2019
·
3 min read
Business

Mesoblast and Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Cell Therapy

Mesoblast and Lonza announced that they have entered into an agreement for commercial manufacture of Mesoblast’s lead allogeneic cell therapy product candidate, remestemcel-L for pediatric steroid-refractory acute graft versus host disease

October 16, 2019
·
6 min read
Pharm Country

Pharmacy Times Continuing Education™ to Host Directions in Oncology Pharmacy™ Conference in New York City

The full-day meeting will feature recognized experts sharing the latest clinical data in oncology while exploring best practices and management strategies

October 16, 2019
·
3 min read
Business

Vitas Healthcare’s Richard La Bella Wins ‘Advocates’ Leadership Award From SC Media

Richard La Bella, chief information security officer at VITAS Healthcare, the nation’s leading provider of end-of-life-care, has been named a winner in the third-annual SC Media Reboot Leadership Awards, earning the distinction in the Advocates category.

October 16, 2019
·
2 min read